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Down syndrome (DS) is caused by a total or partial trisomy of 
chromosome 21 in humans. 
 
The overexpression of the enzyme Superoxide dismutase (SOD) 
located in chromosome 21 leads to an elevated oxidative stress 
which contributes to the pathology of DS (see Figure 1). 
 
Using antioxidants to reduce oxidative stress levels is a promising 
approach for slowing or preventing DS associated features and 
maybe improving cognitive function. 
 
Vitamin E is a lipid-soluble antioxidant that protects from lipid 
peroxidation and DNA damage. The intake of vitamin E might be 
useful in preventing cognitive deterioration in DS. 
Figure 1 Pathway from the increase of SOD 
to the generation of oxidative damage. 
Adapted from Ani et al. (2000) 
Search on the following sites: 
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• www.clinicaltrials.org: Actual clinical trials 
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Objective Introduction 
Materials and Methods 
• Review the studies that have been done on 
the subject of supplementation with 
vitamin E in patients with DS and its 
current state. 
Discussion 
Despite the mostly promising results of in vitro and animal studies, 
interventional studies of vitamin E supplementation in DS human 
subjects have not been conclusive. 
Vitamin E: Isomers and toxicity 
Vitamin E consists of four tocopherol isomers (α, β, γ, δ) and four tocotrienol isomers 
(α, β, γ, δ). They are closely related chemically (see Figure 2) but they differ in their 
biological effectiveness. 
 
• Radical-scavenging activity: α-tocopherol > other tocopherols > tocotrienols                        
>> chemically synthesized α-tocopherol  
  
• There is no consistent proof that vitamin E improves the outcome in DS. 
• Antioxidant intervention should start soon after birth, before the chronic oxidative 
damage is already installed. 
• Well-designed research needs to be done to select the right isomer and dose of 
vitamin E. 
• Theoretically, the best treatment choice would be the natural α-tocopherol 
combined with either other isomers or vitamin C. 
• There are potential adverse effects from high doses and prolonged supplementation. 
The safety of vitamin E should be evaluated.  
• Until we have clear evidence of the benefits of vitamin E supplementation, parents 
should be discouraged of giving it to their children with DS. 
Conclusions 
Figure 2 Natural R,R,R-tocopherols and 
R,R,R-tocotrienols. Adapted from Cook-
Mills, J.M. (2013) 
Possible explanation for the 
lack of effect 
Solutions 
Small sample size Big sample size 
Short-term supplementation Long-term supplementation 
Old individuals Young individuals 
Not enough vitamin E crosses 
the blood-brain barrier 
Supplement with vitamin E and C* 
Outcome measures not 
appropriate 
Standardize outcome measures 
Dose  More basic research 
Isomeric form of vitamin E More basic research 
Protective 
67% (2) 
Not 
protective 
33% (1) 
In vitro 
Results of Vitamin E Supplementation Studies 
Protective  
100% (2) 
Ts65Dn mouse 
Figure 3 Results of in vitro (3), animal model (2) and clinical studies (8). In 67% of in vitro studies, 
100% of animal studies and 12.5% of the clinical  trials,  the supplementation with vitamin E was 
protective. One clinical trial has not published the results yet. 
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Table 1 Problems and solutions of clinical research done on the subject of 
vitamin E supplementation in DS. *Vitamin C seems to improve other 
compounds to cross the blood-brain barrier. 
Superoxide radical 
Hydrogen peroxide 
Hydroxyl radical Water 
SOD 
Fe+ 
GSH-Px 
Catalase 
Lipid peroxidation 
DNA damage 
• Mixtures of different forms of vitamin E 
have a broader range of free-radical-
scavenging abilities. 
 
• High doses of Vitamin E can have toxic 
effects, including apoptotic activity 
(tocotrienols more than tocopherols), 
adverse effects on offspring (high maternal 
α-tocopherol) and hemorrhagic toxicity.  
In vitro studies: Vitamin E is neuroprotective, increases neuronal 
survival and protects from chromosomal damage. 
Animal studies: Vitamin E delays cognitive decline in aged mice and 
improves cognitive deficits in newborn mice. 
Clinical trials: Vitamin E attenuates the systemic oxidative stress. 
In vitro studies: Vitamin E can be apoptotic. 
Clinical trials: Vitamin E does not improve cognitive, psychomotor 
or language development. 
A completed phase III clinical trial (Dalton A, 2012) has not 
published the results yet. This well-designed trial could provide 
definitive evidence as to whether vitamin E can restore cognitive 
function in an aging population with DS.  
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